March 3rd, 2010

Best treatment for small HER-2–positive, node-negative breast cancers unknown

By Beth Backus

HemOnc today
About 25% of breast cancers diagnosed in the United States are HER-2–positive. Research has established that the HER-2 phenotype is associated with poor DFS and OS.

Tags: Mayo Clinic Jacksonville

Contact Us · Privacy Policy